SCHEMBL2918837

SCHEMBL2918837

Fc1cccc(/C(=C/c2cccc(Cl)c2)CCl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.49
PTGS2 P35354 2/20 0.49
GRIN2B Q13224 1/20 0.45
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
KMT2A Q03164 1/20 0.41
GRM5 P41594 3/20 0.40
FBP1 P09467 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.39
MAOB P27338 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
CHRM5 P08912 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
NPC1 O15118 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766762 1.00 PTGS1 (0.49) PTGS1PTGS2GRIN2BKDM4EALDH1A1
SCHEMBL3767391 0.87 PTGS1 (0.50) PTGS1PTGS2GRIN2BALDH1A1PKM
SCHEMBL2920260 0.87 PTGS1 (0.50) PTGS1PTGS2GRIN2BALDH1A1PKM
SCHEMBL2925552 0.83 PTGS1 (0.52) PTGS1PTGS2POLBKMT2ASMN1; SMN2
SCHEMBL3765796 0.83 PTGS1 (0.52) PTGS1PTGS2POLBKMT2ASMN1; SMN2
SCHEMBL3769829 0.81 MDM2 (0.40) PTGS1KDM4EALDH1A1POLBPKM
SCHEMBL3769833 0.81 MDM2 (0.40) PTGS1KDM4EALDH1A1POLBPKM
SCHEMBL3768883 0.80 PTGS1 (0.41) PTGS1PTGS2FBP1CES2CES1
SCHEMBL3768878 0.80 PTGS1 (0.41) PTGS1PTGS2FBP1CES2CES1
SCHEMBL2293804 0.77 NPC1 (0.50) PTGS1PTGS2GRIN2BKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311581-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same BASF SE (DE) 2010-12-09 US disclosed
EP-2224812-A2 AZOLYLMETHYLOXIRANES, USE THEREOF AND AGENTS CONTAINING THE SAME BASF SE (DE) 2010-09-08 EP disclosed
WO-2009077471-A2 AZOLYLMETHYLOXIRANES, USE THEREOF AND AGENTS CONTAINING THE SAME BASF SE (DE) 2009-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311581-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same XDH, DAO, DHODH PTGS1 262/4885PTGS2 369/4885GRIN2B 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.